US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 34.440
  • -0.750-2.13%
Close Feb 26 16:00 ET
  • 35.190
  • +0.750+2.18%
Pre 07:23 ET
1.97BMarket Cap2.96P/E (TTM)

Agios Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Agios Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 13, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
9.35M
10.73M
+1.38M
Beat Est.
+31.60%
+51.06%
+14.79%
EPS
-1.69
-1.74
-0.05
Miss Est.
+1.72%
-1.16%
-2.93%
Analyst Rating
Strong Buy

Feb 24, 2025

Agios Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 10.862M--
--2025/Q1-- / 10.192M--
Feb 13, 20252024/Q410.730M / 9.347M--
Oct 31, 20242024/Q38.964M / 9.502M--
Aug 1, 20242024/Q28.615M / 9.307M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 10.862M--
--2025/Q1-- / 10.192M--
Feb 13, 20252024/Q410.730M / 9.347M--
Oct 31, 20242024/Q38.964M / 9.502M--
Aug 1, 20242024/Q28.615M / 9.307M--

Unlock Free Earnings Estimates

Agios Pharmaceuticals Earnings Reports

  • Agios Pharmaceuticals | 10-K: FY2024 Annual Report

    Feb 13 09:29 ET

  • Agios Pharmaceuticals | 8-K: Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

    Feb 13 06:34 ET

  • Agios Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 31, 2024 09:26 ET

  • Agios Pharmaceuticals | 8-K: Agios Reports Business Highlights and Third Quarter 2024 Financial Results

    Oct 31, 2024 07:00 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +16.49%
    Hutchmed (China)
    HCM
    +6.29%
    Workday
    WDAY
    +6.22%
    DexCom
    DXCM
    +1.80%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +0.62%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 24, 2025

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data